This stock took it on the chops on aspirin “news” that does not affect the target market for Vazalore. PPS is almost where it was PRIOR to FDA approval, which is absurd.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
